Have a question or topic idea for The Life Science Report? Submit it here.
Successful Sell-Side Licensing, Partnering and M&A
Despite the heavy influx of capital over the past years, medtech and biopharma sell-side assignments can still be ripe with challenges. In this episode of Back Bay’s industry podcast, Stephan Gauldie, PhD, Greg Benning and Jonathan P. Gertler, MD of Back Bay Life Science Advisors’ investment banking team discuss best practices for successful sell-side licensing, partnering, and M&A, including:
Best practices for readying vital aspects of deal preparation
Identifying deal issues, red flags ahead of time
Articulation of the path forward, including indication and proof of concept and telling the story through to market
The importance of choosing the right partner and alignment for stakeholders, management, board, investors, internal champions and others
The most significant mistakes made in competitive intelligence, technology, position, IP regulatory strategies
Networking, contacts and how to know who’s going to be responsible for what and when.
Subscribe:
Apple Podcasts | Libsyn | Spotify | Stitcher
